Skip to main content
Biosenta Inc. logo

Biosenta Inc. — Investor Relations & Filings

Ticker · ZRO ISIN · CA09072N2023 CSE Manufacturing
Open in API
Filings indexed 152 across all filing types
Latest filing 2026-01-28 Audit Report / Informat…
Country CA Canada
Listing CSE ZRO

About Biosenta Inc.

https://www.biosenta.com

Biosenta Inc. develops, manufactures, and sells innovative, eco-friendly antimicrobial chemical compounds utilizing encapsulated nanotechnology. The company specializes in producing state-of-the-art solutions designed to eliminate harmful microorganisms for household and industrial applications. Biosenta's product portfolio includes Tri-Filler, a revolutionary anti-microbial filler used in soft and hard textiles. The company focuses on setting new global standards by delivering effective cleaning and material solutions that prioritize human and environmental safety.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Audit Report / Information Classification · 95% confidence The document is a 'Form 52-109FV1', which is a Venture Issuer Basic Certificate required under Canadian securities legislation to accompany annual filings. It serves as a formal certification by the CEO regarding the accuracy and fair presentation of the company's annual financial statements and MD&A. Since it is a regulatory certification document that does not fit into the primary financial reporting categories (like 10-K or IR) and is not an announcement of a report, it falls under the 'Regulatory Filings' category. FY 2025
2026-01-28 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Audit Report / Information Classification · 95% confidence The document is a 'Form 52-109FV1', which is a Venture Issuer Basic Certificate used in Canadian securities regulation to certify annual filings. It is a standalone regulatory certification document signed by the CFO, confirming the accuracy of the annual financial statements and MD&A. Since it is a specific regulatory certification document rather than the annual report itself, and it does not fit into the other specific categories like 10-K or AR, it is best classified as a Regulatory Filing. FY 2025
2026-01-28 English
Annual MD&A - English.pdf
Management Reports Classification · 100% confidence The document is explicitly titled 'Management’s Discussion & Analysis' (MD&A) for the year ended September 30, 2025. It provides a detailed review of the company's business, strategy, intellectual property, and financial performance, which is the standard content for an MD&A report. While it references annual financial statements, the document itself is the management's narrative analysis of those results, fitting the definition of the MDA category.
2026-01-28 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Audit Report / Information Classification · 95% confidence The document is a 'Certification of Annual Filings' (Form 52-109FV1) signed by the CEO of Stuve Gold Corp. This is a regulatory requirement for venture issuers to certify the accuracy of their annual financial statements and MD&A. Since it is a standalone regulatory certification document rather than the annual report itself, and it does not fit into the other specific categories like 'Annual Report' (10-K) or 'Management Reports' (MDA), it is best classified as a Regulatory Filing. FY 2021
2026-01-28 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Audit Report / Information Classification · 95% confidence The document is a 'Form 52-109FV2 Certification of Annual Filings', which is a regulatory requirement for venture issuers to certify the accuracy of their annual financial statements and MD&A. It is not the annual report itself, but a specific regulatory certification document. Since it does not fit into the specific categories like 10-K or AR (which are the reports themselves), and it is a formal regulatory filing required by securities legislation, it falls under the 'Regulatory Filings' category. FY 2021
2026-01-28 English
Audited annual financial statements – English.pdf
Annual Report Classification · 100% confidence The document is titled 'Consolidated Financial Statements' for Biosenta Inc. for the years ended September 30, 2025 and 2024. It includes an Independent Auditor's Report, Consolidated Statements of Financial Position, Statements of Operations and Comprehensive Loss, and Statements of Changes in Shareholders' Deficit. This is a comprehensive annual financial report, which falls under the 10-K category for annual reporting. FY 2025
2026-01-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.